, Tracking Stock Market Picks
Enter Symbol:
Five Prime Therapeutics Inc. (FPRX) [hlAlert]

up 36.93 %

Five Prime Therapeutics Inc. (FPRX) rated Outperform by Wells Fargo

Posted on: Friday,  Dec 4, 2015  10:25 AM ET by Wells Fargo

Wells Fargo rated Outperform Five Prime Therapeutics Inc. (NASDAQ: FPRX) on 12/04/2015. Previously Wells Fargo rated Outperform Five Prime Therapeutics Inc. (NASDAQ: FPRX)
on 10/14/2013., when the stock price was $13.70. Since then, Five Prime Therapeutics Inc. has gained 36.93% as of 01/22/2016's recent price of $18.76.
If you would have followed the previous Wells Fargo's recommendation on FPRX, you would have gained 36.93% of your investment in 830 days.

The investment research content is provided by Wells Capital Management, a registered investment adviser and wholly owned subsidiary of Wells Fargo Bank, N.A. Our economists’ expertise on domestic markets, and national and global trends, is an important resource to the firm. Wells Capital Management economists are known for their thoughts on investment strategy, macro-economic forecasts and other top-down analysis, and share their views on bonds, midcaps and liquidity management in their publications.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/4/2015 10:25 AM Buy
as of 8/27/2015
1 Week down  -6.99 %
1 Month down  -26.17 %
3 Months down  -11.38 %
1 YTD up  11.73 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/14/2013 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy